Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2011

Open Access 01-12-2011 | Research article

Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes

Authors: Kazutaka Sakamoto, Makoto Osaki, Akira Hozumi, Hisataka Goto, Tatsuya Fukushima, Hideo Baba, Hiroyuki Shindo

Published in: BMC Musculoskeletal Disorders | Issue 1/2011

Login to get access

Abstract

Background

Osteonecrosis of the femoral head is a common complication of high-dose glucocorticoid treatment. Intravascular thrombosis is thought to be associated with the ischemic state of the femoral head. Plasminogen activator inhibitor-1 (PAI-1) is an adipokine, which are physiologically active substances secreted from visceral and subcutaneous adipocytes. PAI-1 suppresses fibrinolysis by binding tissue-type plasminogen activator. Several reports have described the relationship between PAI-1 and steroid-induced osteonecrosis of the femoral head, and the preventive effects of lipid-lowering agents (statins) against steroid-induced osteonecrosis of the femoral head. We previously reported that adipokines and dexamethasone induced PAI-1 secretion from bone marrow adipocytes. The purpose of the present study is to examine the effects of simvastatin on PAI-1 secretion from human bone marrow adipocytes in vitro.

Methods

Primary bone marrow adipocytes were extracted from collagenase-treated bone marrow fluid obtained from the femoral necks of 40 patients (6 men, 34 women; age range, 52-81 years) undergoing hip joint replacement surgery. After suspended culture with or without dexamethasone or simvastatin, PAI-1 mRNA expression was assessed by real-time RT-PCR. Total PAI-1 protein secretion in culture medium was assessed by enzyme-linked immunosorbent assay.

Results

PAI-1 mRNA expression was up-regulated by 388% (P = 0.002) with dexamethasone, and down-regulated by 45% (P = 0.002) with simvastatin, as compared to control levels. Dexamethasone increased total PAI-1 secretion by 166% (P = 0.001) and simvastatin decreased total PAI-1 secretion by 64% (P = 0.002). No significant changes were observed in adiponectin mRNA expression and secretion by dexamethasone and simvastatin, while pre-treatment with simvastatin reversed dexamethasone induced PAI-1 secretion by 89%, as compared to control levels.

Conclusion

The present study confirmed the suppressive effects of simvastatin on PAI-1 expression and secretion from bone marrow adipocytes. Furthermore, pre-treatment with simvastatin reversed dexamethasone induced PAI-1 secretion. Simvastatin may thus exhibit preventive effects against steroid-induced osteonecrosis of the femoral head by suppressing PAI-1 secretion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P: The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res. 1999, 366: 133-146.CrossRefPubMed Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P: The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res. 1999, 366: 133-146.CrossRefPubMed
2.
go back to reference Posan E, Szepesi K, Gaspar L, Csernatony Z, Harsfalvi J, Ajzner E, Toth A, Udvardy M: Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis. 2003, 14: 243-248.PubMed Posan E, Szepesi K, Gaspar L, Csernatony Z, Harsfalvi J, Ajzner E, Toth A, Udvardy M: Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis. 2003, 14: 243-248.PubMed
3.
go back to reference Mont MA, Ulrich SD, Seyler TM: Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J Rheumatol. 2007, 34: 466-468.PubMed Mont MA, Ulrich SD, Seyler TM: Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J Rheumatol. 2007, 34: 466-468.PubMed
4.
go back to reference Yin L, Li YB, Wang YS: Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chi Med J. 2006, 199: 581-588. Yin L, Li YB, Wang YS: Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chi Med J. 2006, 199: 581-588.
5.
go back to reference Murata M, Kumagai K, Miyata N, Osaki M, Shindo H: Osteonecrosis in stroke-prone spontaneously hypertensive rats: effect of glucocorticoid. J Orthop Sci. 2007, 12: 289-295.CrossRefPubMed Murata M, Kumagai K, Miyata N, Osaki M, Shindo H: Osteonecrosis in stroke-prone spontaneously hypertensive rats: effect of glucocorticoid. J Orthop Sci. 2007, 12: 289-295.CrossRefPubMed
6.
go back to reference Kerachian MA, Seguin C, Harvey EJ: Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009, 114: 121-128.CrossRefPubMed Kerachian MA, Seguin C, Harvey EJ: Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009, 114: 121-128.CrossRefPubMed
7.
go back to reference Okada Y, Tanikawa T, Iida T, Tanaka Y: Vascular injury by glucocorticoid; involvement of apoptosis of endothelial cells. Clin Calcium. 2007, 17: 872-877.PubMed Okada Y, Tanikawa T, Iida T, Tanaka Y: Vascular injury by glucocorticoid; involvement of apoptosis of endothelial cells. Clin Calcium. 2007, 17: 872-877.PubMed
8.
go back to reference Motomura G, Yamamoto T, Miyanishi K, Yamashita A, Sueishi K, Iwamoto Y: Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis--a histomorphometric study of autopsy cases. Pathol Res Pract. 2005, 200: 807-811.CrossRefPubMed Motomura G, Yamamoto T, Miyanishi K, Yamashita A, Sueishi K, Iwamoto Y: Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis--a histomorphometric study of autopsy cases. Pathol Res Pract. 2005, 200: 807-811.CrossRefPubMed
9.
go back to reference Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, Iwamoto Y: Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone. 2002, 30: 185-190.CrossRefPubMed Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, Iwamoto Y: Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone. 2002, 30: 185-190.CrossRefPubMed
10.
11.
go back to reference Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006, 64: 355-365. Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006, 64: 355-365.
12.
go back to reference Hozumi A, Osaki M, Goto H, Sakamoto K, Inokuchi S, Shindo H: Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. Biochem Biophys Res Commun. 2009, 382: 780-784.CrossRefPubMed Hozumi A, Osaki M, Goto H, Sakamoto K, Inokuchi S, Shindo H: Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. Biochem Biophys Res Commun. 2009, 382: 780-784.CrossRefPubMed
13.
go back to reference Lara-Castro C, Fu Y, Chung BH, Garvey WT: Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007, 18: 263-270.CrossRefPubMed Lara-Castro C, Fu Y, Chung BH, Garvey WT: Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007, 18: 263-270.CrossRefPubMed
14.
go back to reference Alessi MC, Poggi M, Juhan-Vague I: Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol. 2007, 18: 240-245.CrossRefPubMed Alessi MC, Poggi M, Juhan-Vague I: Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol. 2007, 18: 240-245.CrossRefPubMed
15.
go back to reference Miyanishi K, Kamo Y, Ihara H, Naka T, Hirakawa M, Sugioka Y: Risk factors for dysbaric osteonecrosis. Rheumatology (Oxf). 2006, 45: 855-858.CrossRef Miyanishi K, Kamo Y, Ihara H, Naka T, Hirakawa M, Sugioka Y: Risk factors for dysbaric osteonecrosis. Rheumatology (Oxf). 2006, 45: 855-858.CrossRef
16.
go back to reference Kang P, Shen B, Yang J, Pei F: Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb Res. 2008, 123: 367-373.CrossRefPubMed Kang P, Shen B, Yang J, Pei F: Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb Res. 2008, 123: 367-373.CrossRefPubMed
17.
go back to reference Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS: Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol. 1993, 44: 243-248.CrossRefPubMed Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS: Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol. 1993, 44: 243-248.CrossRefPubMed
18.
go back to reference Tan X, Cai D, Wu Y, Liu B, Rong L, Chen Z, Zhao Q: Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. Transl Res. 2006, 148: 114-119.CrossRefPubMed Tan X, Cai D, Wu Y, Liu B, Rong L, Chen Z, Zhao Q: Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. Transl Res. 2006, 148: 114-119.CrossRefPubMed
19.
go back to reference Hozumi A, Osaki M, Sakamoto K, Goto H, Fukushima T, Baba H, Shindo H: Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes. Biomedical Research. 2010, 31: 281-286.CrossRefPubMed Hozumi A, Osaki M, Sakamoto K, Goto H, Fukushima T, Baba H, Shindo H: Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes. Biomedical Research. 2010, 31: 281-286.CrossRefPubMed
20.
go back to reference Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y: Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum. 2004, 50: 3387-3391.CrossRefPubMed Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y: Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum. 2004, 50: 3387-3391.CrossRefPubMed
21.
go back to reference Pritchett JW: Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001, 173-178. Pritchett JW: Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001, 173-178.
22.
go back to reference Pengde K, Hong G, Fuxing P, Bin S, Jing Y, Zongke Z: Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Int J Exp Path. 2010, 91: 235-243.CrossRef Pengde K, Hong G, Fuxing P, Bin S, Jing Y, Zongke Z: Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Int J Exp Path. 2010, 91: 235-243.CrossRef
23.
go back to reference Pengde K, Fuxing P, Bin S, Jing Y, Jingqiu C: Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine. 2008, 75: 696-701.CrossRefPubMed Pengde K, Fuxing P, Bin S, Jing Y, Jingqiu C: Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine. 2008, 75: 696-701.CrossRefPubMed
24.
go back to reference Kitajima M, Shigematsu M, Ogawa K, Sugihara H, Hotokebuchi T: Effects of glucocorticoid on adipocyte size in human bone marrow. Med Mol Morphol. 2007, 40: 150-156.CrossRefPubMed Kitajima M, Shigematsu M, Ogawa K, Sugihara H, Hotokebuchi T: Effects of glucocorticoid on adipocyte size in human bone marrow. Med Mol Morphol. 2007, 40: 150-156.CrossRefPubMed
25.
go back to reference Zhang G, Qin L, Sheng H, Wang XL, Wang YX, Yeung DK, Griffith JF, Yao XS, Xie XH, Li ZR, Lee KM, Leung KS: A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone. 2009, 44: 345-356.CrossRefPubMed Zhang G, Qin L, Sheng H, Wang XL, Wang YX, Yeung DK, Griffith JF, Yao XS, Xie XH, Li ZR, Lee KM, Leung KS: A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone. 2009, 44: 345-356.CrossRefPubMed
26.
go back to reference Nishida K, Yamamoto T, Motomura G, Jingushi S, Iwamoto Y: Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits. Clin Orthop Relat Res. 2008, 466: 1054-1058.CrossRefPubMedPubMedCentral Nishida K, Yamamoto T, Motomura G, Jingushi S, Iwamoto Y: Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits. Clin Orthop Relat Res. 2008, 466: 1054-1058.CrossRefPubMedPubMedCentral
27.
go back to reference Laumen H, Skurk T, Hauner H: The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. Atherosclerosis. 2008, 196: 565-573.CrossRefPubMed Laumen H, Skurk T, Hauner H: The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. Atherosclerosis. 2008, 196: 565-573.CrossRefPubMed
28.
go back to reference Li JQ, Zhao SP, Li QZ, Cai YC, Wu LR, Fang Y, Li P: Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. Clin Chim Acta. 2006, 370: 57-62.CrossRefPubMed Li JQ, Zhao SP, Li QZ, Cai YC, Wu LR, Fang Y, Li P: Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. Clin Chim Acta. 2006, 370: 57-62.CrossRefPubMed
29.
go back to reference Essig M, Nguyen G, Prie D, Escoubet B, Sraer JD, Friedlander G: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res. 1998, 83: 683-690.CrossRefPubMed Essig M, Nguyen G, Prie D, Escoubet B, Sraer JD, Friedlander G: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res. 1998, 83: 683-690.CrossRefPubMed
30.
go back to reference Markle RA, Han J, Summers BD, Yokoyama T, Hajjar KA, Hajjar DP, Gotto AM, Nicholson AC: Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem. 2003, 90: 23-32.CrossRefPubMed Markle RA, Han J, Summers BD, Yokoyama T, Hajjar KA, Hajjar DP, Gotto AM, Nicholson AC: Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem. 2003, 90: 23-32.CrossRefPubMed
31.
go back to reference Kunieda Y, Nakagawa K, Nishimura H, Kato H, Ukimura N, Yano S, Kawano H, Kimura S, Nakagawa M, Tsuji H: HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thromb Res. 2003, 110: 227-234.CrossRefPubMed Kunieda Y, Nakagawa K, Nishimura H, Kato H, Ukimura N, Yano S, Kawano H, Kimura S, Nakagawa M, Tsuji H: HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thromb Res. 2003, 110: 227-234.CrossRefPubMed
32.
go back to reference Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, Sobel BE, Fujii S: Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Coron Artery Dis. 2008, 19: 355-361.CrossRefPubMed Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, Sobel BE, Fujii S: Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Coron Artery Dis. 2008, 19: 355-361.CrossRefPubMed
33.
go back to reference Kruithof EK: Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost. 2008, 100: 969-975.PubMed Kruithof EK: Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost. 2008, 100: 969-975.PubMed
34.
go back to reference Essig M, Vrtovsnik F, Nguyen G, Sraer JD, Friedlander G: Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J Am Soc Nephrol. 1998, 9: 1377-1388.PubMed Essig M, Vrtovsnik F, Nguyen G, Sraer JD, Friedlander G: Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J Am Soc Nephrol. 1998, 9: 1377-1388.PubMed
35.
go back to reference Ishibashi T, Nagata K, Ohkawara H, Sakamoto T, Yokoyama K, Shindo J, Sugimoto K, Sakurada S, Takuwa Y, Teramoto T, Maruyama Y: Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes. Biochim Biophys Acta. 2002, 1590: 123-130.CrossRefPubMed Ishibashi T, Nagata K, Ohkawara H, Sakamoto T, Yokoyama K, Shindo J, Sugimoto K, Sakurada S, Takuwa Y, Teramoto T, Maruyama Y: Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes. Biochim Biophys Acta. 2002, 1590: 123-130.CrossRefPubMed
36.
go back to reference Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K: Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci. 2008, 13: 463-468.CrossRefPubMed Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K: Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci. 2008, 13: 463-468.CrossRefPubMed
37.
go back to reference Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K, Takaoka K: Low hepatic cytochrome P4503A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther. 2006, 80: 396-402.CrossRefPubMed Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K, Takaoka K: Low hepatic cytochrome P4503A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther. 2006, 80: 396-402.CrossRefPubMed
38.
go back to reference Horsmans Y, Desager JP, van den Berge V, Abrassart M, Harvengt C: Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A. Pharmacol Res. 1993, 28: 243-248. Horsmans Y, Desager JP, van den Berge V, Abrassart M, Harvengt C: Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A. Pharmacol Res. 1993, 28: 243-248.
39.
go back to reference Halleux CM, Servais I, Reul BA, Detry R, Brichard SM: Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab. 1998, 83: 902-910.PubMed Halleux CM, Servais I, Reul BA, Detry R, Brichard SM: Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab. 1998, 83: 902-910.PubMed
40.
go back to reference Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, Vidal-Puig A, Jones R, Considine RV: Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res. 2005, 13: 662-669.CrossRefPubMed Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, Vidal-Puig A, Jones R, Considine RV: Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res. 2005, 13: 662-669.CrossRefPubMed
Metadata
Title
Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes
Authors
Kazutaka Sakamoto
Makoto Osaki
Akira Hozumi
Hisataka Goto
Tatsuya Fukushima
Hideo Baba
Hiroyuki Shindo
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2011
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-12-82

Other articles of this Issue 1/2011

BMC Musculoskeletal Disorders 1/2011 Go to the issue